Skip to main content

Current Trends and Future Outlooks of Dental Stem-Cell-Derived Secretome/Conditioned Medium in Regenerative Medicine

  • Living reference work entry
  • First Online:
Handbook of Stem Cell Therapy

Abstract

Constructing biological substitutes that mimic the structure, architecture, and function of different tissues and organs is the ultimate goal of regenerative medicine. Adult mesenchymal stem/progenitor cells (MSCs) are considered the most widely researched cells in regenerative applications, yet several obstacles that challenge the safe and effective clinical translation of MSC-based therapies still exist. MSCs could partially exert their reparative and regenerative impact through a paracrine effect, mediated by the release of bioactive and trophic factors known as secretome, rather than the actual presence of the engrafted cells in the target site. In addition, MSCs have shown the ability to secrete these various bioactive molecules in their surrounding media (the conditioned media (CM)). MSC-secretome/CM is a set of proteins, lipids, nucleic acids, and trophic factors such as cytokines, chemokines, hormones, growth factors, and extracellular vesicles (EVs). Compared to nondental MSC secretome, dental MSC secretome/CM revealed a higher expression of proliferation-related, metabolic, transcriptional proteins and chemokines, as well as neurotrophins. Dental MSC secretome/CM exhibited experimentally tremendous biological effects, including immunomodulatory, anti-inflammatory, neuroprotective, osteogenic, angiogenic, and antiapoptotic effects, as well as the modulation of oxidative stresses. These aforementioned biological effects greatly explain the increasing interest in dental MSC secretome/CM as an acellular regenerative strategy for the treatment of various clinical diseases/injuries while alleviating the limitations and safety concerns associated with MSC-based therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Abbreviations

3D:

Three-dimensional

ABMSCs:

Alveolar bone proper-derived stem/progenitor cells

AD:

Alzheimer’s disease

ALS:

Amyotrophic lateral sclerosis

ASCs:

Adipose stem/progenitor cells

bFGF:

Basic fibroblast growth factor

BMMSCs:

Bone-marrow-derived mesenchymal stem/progenitor cells

BMP:

Bone morphogenetic protein

BNDF:

Brain-derived neurotrophic factor

BSP:

Bone sialoprotein

CCK-8:

Cell count kit-8

c-JUN/JNK:

c-JUN/N-terminal kinase

CM:

Conditioned medium

CSF:

Colony-stimulating factor

CXCL:

CXC motif ligand

DFSCs:

Dental follicle stem/progenitor cells

DMSCs:

Dental mesenchymal stem/progenitor cells

DPSCs:

Dental pulp stem/progenitor cells

DSPP:

Dentin sialophosphoprotein

EAE:

Encephalomyelitis

ECM:

Extracellular matrix

EGF:

Epidermal growth factor

EMVs:

Exosomes/Matrix vesicles

EVs:

Extracellular vesicles

EXs:

Exosomes

FGF:

Fibroblast growth factor

FGF-R:

Fibroblast growth factor-receptor

FLT-3:

Fms-like tyrosine kinase receptor-3

GCSF:

Granulocyte-colony-stimulating factor

GDNF:

Glial-cell-line-derived neurotrophic factor

GFAP:

Glial fibrillary acidic protein

GM-CSF:

Granulocyte-macrophage colony stimulating factor

GMSCs:

Gingival mesenchymal stem cells

HEGF:

Heparin-binding epidermal growth factor

HFSCs:

Hair follicle stem cells-CM

HGF:

Hepatocyte growth factor

HLA-DR:

Human leukocyte antigen-DR isotype

HUVECs:

Human umbilical vein endothelial cell culture

IFNγ:

Interferon gamma

IGF:

Insulin-like growth factor

IL:

Interleukins

iNOS:

Inducible nitric-oxide synthase

KGF:

Keratinocyte growth factor

LF:

Liver failure

MAPK:

Mitogen-activated protein kinase

MCP-1:

Monocyte chemoattractant protein-1

MS:

Multiple sclerosis

MSCs:

Mesenchymal stem/progenitor cells

MVs:

Microvesicles

NF-Κb:

Nuclear factor-kappa B

NGF:

Neural growth factor

NT-3:

Neurotrophin-3

OCN:

Osteocalcin

Oct:

Octamer-binding transcription factor

OSM:

Oncostatin M

PCNA:

Proliferating cell nuclear antigen

PDEGF:

Platelet-derived endothelial cell growth factor

PDGF:

Platelet-derived growth factor

PDL:

Periodontal ligament

PDLSCs:

Periodontal ligament stem/progenitor cells

PEI:

Polyethyleneimine

PGE2:

Prostaglandin E2

PLA:

Poly-(lactide)

RUNX2:

Runt-related transcription factor 2

SCAP:

Stem/progenitor cells from apical dental papilla

SCF:

Stem cell factor

SDF:

Stromal-cell-derived factor

SHED:

Human shed deciduous teeth

SOD:

Superoxide dismutase

SOX-2:

Sex-determining region Y (SRY)-box 2

sSiglec-9:

Soluble sialic-acid-binding Ig-like lectin-9

TFIP11:

Tuftelin-interacting protein

TGF-β:

Transforming growth factor β

TIMP:

Tissue inhibitor of metalloproteinase

TLR:

Toll-like receptor

TNF-α:

Tumor necrosis factor-α

TRAP:

Tartrate-resistant acid phosphatase

TUFT1:

Tuftelin 1

VEGF:

Vascular endothelial growth factor

References

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Section Editor information

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Singapore Pte Ltd.

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Radwan, I.A. et al. (2022). Current Trends and Future Outlooks of Dental Stem-Cell-Derived Secretome/Conditioned Medium in Regenerative Medicine. In: Haider, K.H. (eds) Handbook of Stem Cell Therapy. Springer, Singapore. https://doi.org/10.1007/978-981-16-6016-0_47-1

Download citation

  • DOI: https://doi.org/10.1007/978-981-16-6016-0_47-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-16-6016-0

  • Online ISBN: 978-981-16-6016-0

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics